Percutaneous ablation and the battle against primary lung cancer: A review of current techniques
Lung cancer is the most common type of primary cancer worldwide. In the UK, less than 10% of people diagnosed with lung cancer will survive beyond five years and the disease is responsible for approximately 35,000 deaths per annum. In 2010, 34,859 patients died of lung cancer, 56% men, 44% women, Cancer Research UK. Primary […]
Gemma Marshall, Corey Frazer
Harefield Hospital